Lexeo Therapeutics, Inc. (LXEO) stock
LXEONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.85−0.38 (-11.61%)
Close on Nov 17, 2026Market cap $234.24MP/E –Yield –
Lexeo Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Lexeo Therapeutics's enterprise value was $7.17M on Nov 11, 2026, against $418.89M a year earlier. Over the last 3 years it ranged from -$33.92M to $422.73M, with a median of $120.45M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $7.17M | -98.3% |
| 2025 | Dec 31, 2025 | $422.73M | +638.4% |
| 2024 | Dec 31, 2024 | $57.25M | – |
| 2023 | Dec 29, 2023 | -$16.78M | – |
See a number that looks wrong?